0.9411
price up icon0.78%   0.0073
 
loading

Pharmacyte Biotech Inc Azioni (PMCB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
8.50%
1.0419
0.9603 1.1061 1.2689 3.1662
Operating Income/Loss
8.50%
-1.0419
-0.9603 -1.1061 -1.2689 -3.1662
Nonoperating Income/Loss
713.48%
12.79
-2.0851 -0.3635 24.69 4.5129
Income/Loss From Continuing Operations Before Tax
292.91%
11.75
-6.0907 -1.4696 23.42 1.3467
Income/Loss From Continuing Operations After Tax
292.91%
11.75
-6.0907 -1.4696 23.42 1.3467
Net Income/Loss
292.91%
11.75
-6.0907 -1.4696 23.42 1.3467
Preferred Stock Dividends And Other Adjustments
2.9708
- - - 3.8872
Attributable To Noncontrolling Interest
100.00%
-
-3.0453 -2.9589 - -
Basic Average Shares
102.27%
-0.1582
6.96 7.637 7.8664 -0.4103
Diluted Average Shares
102.27%
-0.1582
6.96 7.637 7.8664 -0.4103
Basic Earnings Per Share
445.45%
1.52
-0.44 -0.39 1.90 -0.33
Diluted Earnings Per Share
445.45%
1.52
-0.44 -0.39 1.90 -0.33
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
736.85%
10.85
-1.7031 -0.7388 14.96 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
13.82
- - - 3.8872
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):